
Earnings Insights
AI-generated analysis of quarterly earnings, concall highlights, and financial performance across Indian listed companies.
How to use these insights
Each article is built from earnings call transcripts and structured rank signals. Start with the latest summary, then open the stock page for the full company view, the concall page for quarter-by-quarter commentary, and the rankings dashboard to compare peers.
Castrol India Q4 FY26 earnings call: Revenue & Margins | Arthneeti
Q4 FY26
Overall volume growth is around 7%-8% year-on-year, influenced by slower growth in commercial and specialty industrial products. Key concall takeaways from…
16 Aug 2026
India Cements Q4 FY26 earnings call: Revenue & Margins | Arthneeti
Q4 FY26
Volume growth continues with Q4 FY26 consolidated sales volumes at 44 million tons and UltraTech brand volumes growing 19% YoY. Key concall takeaways from…
16 Aug 2026
Adani Total Gas Q4 FY26 earnings call: Revenue & Margins | Arthneeti
Q4 FY26
. Key concall takeaways from Adani Total Gas's Q4 FY26 earnings call — and how it ranks against sector peers.
16 Aug 2026
Capital Small Finance Bank Q4 FY26 earnings call: Revenue & Margins | Arthneeti
Q4 FY26
Currently, Banca contributes around ₹9.5 crores to operating income, covering life insurance, general insurance, health, MTSS, and 3in1 products. Key concall…
16 Aug 2026
Fedbank Financial Services Q4 FY26 earnings call: Revenue & Margins | Arthneeti
Q4 FY26
Comfortable capital adequacy (CRAR 22.4%) and leverage (4.6x) provide headroom for expansion. Key concall takeaways from Fedbank Financial Services Ltd's Q4…
16 Aug 2026
UCO Bank Q4 FY26 earnings call: Revenue & Margins | Arthneeti
Q4 FY26
Credit pipeline of Rs.14,000 crore in Corporates focuses on renewables, data centers, smart metering, and roads but pricing discipline is maintained. Key…
16 Aug 2026
Bandhan Bank Q4 FY26 earnings call: Revenue & Margins | Arthneeti
Q4 FY26
The EEB (microfinance) segment showed 8% sequential growth QoQ with focus on improving other income from the secured book, not just interest income. Key…
16 Aug 2026
Sudeep Pharma Q2 FY26 earnings call: Revenue & Margins | Arthneeti
Q2 FY26
NSS acquisition to drive European expansion with a focus on PAN-Europe growth; infant nutrition (70-75% of NSS revenue) is a key area. Key concall takeaways…
16 Aug 2026
Tanla Platforms Q4 FY26 earnings call: Revenue & Margins | Arthneeti
Q4 FY26
SMS volumes growing due to regulatory mandates, despite some pricing pressure; overall CPaaS industry revenue growth around 8-10% annually with potential for…
16 Aug 2026
Greenply Industries Q4 FY26 earnings call: Revenue & Margins | Arthneeti
Q4 FY26
The recently operational PVC/WPC plant has a potential peak revenue of INR 75-80 crores, contributing to future growth. Key concall takeaways from Greenply…
16 Aug 2026
Emmvee Photovol. Q4 FY26 earnings call: Revenue & Margins | Arthneeti
Q4 FY26
FY2026 saw strong financial performance with revenue up 116% YoY to INR 5,049 crores and EBITDA up 140% YoY to INR 1,734 crores. Key concall takeaways from…
16 Aug 2026
Canara Robeco Asset Management Company Q4 FY26 earnings call: Revenue & Margins | Arthneeti
Q4 FY26
Continued growth in average AUM (14% YoY) and expanding distribution network (56,000+ partners) support volume increases. Key concall takeaways from Canara…
16 Aug 2026
Sunlite Recycling Industries Q4 FY26 earnings call: Revenue & Margins | Arthneeti
Q4 FY26
PAT growth may be around 30% in FY27 based on current H2 PAT run rate. Key concall takeaways from Sunlite Recycling Industries Ltd's Q4 FY26 earnings call…
16 Aug 2026
City Union Bank Q4 FY26 earnings call: Revenue & Margins | Arthneeti
Q4 FY26
Total business growth in FY26 was 24%, the highest in recent years, with consistent double-digit growth over the last eight quarters. Key concall takeaways…
16 Aug 2026
Newgen Software Technologies Q4 FY26 earnings call: Revenue & Margins | Arthneeti
Q4 FY26
Annual order book grew by ~13%, indicating a healthy pipeline. Key concall takeaways from Newgen Software Technologies Ltd's Q4 FY26 earnings call — and how it…
16 Aug 2026
Jagsonpal Pharmaceuticals Q4 FY26 earnings call: Revenue & Margins | Arthneeti
Q4 FY26
Volume growth for FY26 was 2% for Jagsonpal, slightly higher than the market's ~1%. Key concall takeaways from Jagsonpal Pharmaceuticals Ltd's Q4 FY26 earnings…
16 Aug 2026
Go Digit General Q4 FY26 earnings call: Revenue & Margins | Arthneeti
Q4 FY26
For fiscal years '25 and '26, retail health business is under 6% of total health segment, indicating room for growth. Key concall takeaways from Go Digit…
16 Aug 2026
Viyash Scientific Q2 FY26 earnings call: Revenue & Margins | Arthneeti
Q2 FY26
Around INR 60 crores spent recently by Viyash. Key concall takeaways from Viyash Scientific Ltd's Q2 FY26 earnings call — and how it ranks against sector peers.
16 Aug 2026
Navin Fluo.Intl. Q4 FY26 earnings call: Revenue & Margins | Arthneeti
Q4 FY26
Q4 FY26 revenue up 39% YoY; ongoing scale-up in existing and new molecules. Key concall takeaways from Navin Fluo.Intl.'s Q4 FY26 earnings call — and how it…
16 Aug 2026
Titan Company Q2 FY26 earnings call: Revenue & Margins | Arthneeti
Q2 FY26
. Key concall takeaways from Titan Company's Q2 FY26 earnings call — and how it ranks against sector peers.
16 Aug 2026